Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06184464
Prostatic Size Reduction Following of Leuprorelin Acetate
Sponsor: Consorci Sanitari de Terrassa
View on ClinicalTrials.gov
Summary
To determine the possible reduction in prostate size following the administration of Leuprelin prior to the application of radiotherapy.
Official title: Prostatic Size Reduction Following the Administration of Leuprorelin Acetate in Localized Prostate Cancer Prior to Radiation Therapy. Pilot Study.
Key Details
Gender
MALE
Age Range
18 Years - 95 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2024-02-02
Completion Date
2024-12-15
Last Updated
2024-09-19
Healthy Volunteers
No
Interventions
OTHER
ACETATE LEUPRELINE
USE ACETATE LEUPRELINE BEFORE AND AFTER PROSTATE DELIMITATION
Locations (1)
Hospital de Terrassa
Terrassa, Barcelona, Spain